Self-Contained Irradiator Radiation Safety

Introduction

A self-contained irradiator looks like an appliance, but inside it is one of the most concentrated radioactive sources a hospital or research building will ever hold — and three facts about it shape the entire radiation safety program. First, it is not a "Part 36" irradiator, so the rules many people reach for do not apply. Second, its cesium-137 source is large enough to be a physical-security concern under 10 CFR Part 37. Third, the dose it delivers drifts downward as the source decays, so the timer that seems to "just work" is quietly going out of calibration. ^{1, 3, 5}

Self-contained (self-shielded) irradiators are shielded cabinets in which a sealed gamma source — usually cesium-137 or cobalt-60 — or an x-ray tube delivers a precise, high dose to a small sample placed inside. The two most common uses are blood irradiation, which prevents transfusion-associated graft-versus-host disease (TA-GVHD), and research irradiation of cells and small animals. During normal operation nobody is exposed, because the source stays behind heavy shielding and the sample is moved into the beam mechanically. That very safety is what can make the program complacent. ^{5, 6}

This guide explains what these devices are, the regulatory framework that actually governs them, the physics of dose delivery and source decay, the security dimension that increasingly drives national policy, and the practical radiation safety program the Radiation Safety Officer (RSO) must run. DRPS supports these programs through its Radiation Safety Officer consulting, radioactive material license support, and radiation safety training services across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Topic Explanation

What a self-contained irradiator is — and is not

The defining feature is that both the source and the irradiation volume are contained within the device and are not accessible to personnel during operation. A blood irradiator, for example, holds the blood unit in a rotating canister that is lowered next to (or between) sealed sources; a research irradiator does the same for culture flasks or cages. The shielding — lead, depleted uranium, or steel — keeps external dose rates at the accessible surfaces low even though the internal source is very large. ⁵

This is fundamentally different from the large panoramic and underwater (pool-type) irradiators used for sterilization and food processing, where product moves through a shielded room past an exposed source array. Those big irradiators are what 10 CFR Part 36 governs — and Part 36 explicitly does not apply to self-shielded irradiators or to irradiators used to medically treat humans or animals. Confusing the two is the single most common regulatory misunderstanding about these devices. ¹

The two source choices, and increasingly a third

Feature	Cesium-137	Cobalt-60	X-ray irradiator
Photon energy	662 keV	1.17 and 1.33 MeV	Bremsstrahlung spectrum (e.g., ~160 kV)
Half-life	~30.1 years	~5.27 years	Not applicable (no source)
Output drift	Slow (~2%/year)	Faster (~1%/month)	Stable while powered
Typical activity	~1,000–2,500 Ci	Hundreds of Ci	No radioactive material
Part 37 security	Usually applies	May apply	Does not apply
Long-term burden	Leak test, security, disposal	Recalibration, security, disposal	Tube/electrical maintenance

Cesium-137's long half-life made it attractive for stable, low-maintenance blood irradiators, but its chemical form (cesium chloride, a fine dispersible powder) is exactly what makes it a security liability. Cobalt-60's shorter half-life means the dose rate falls fast enough that the delivery timer must be updated frequently. X-ray irradiators avoid a radioactive source entirely, which is why they now dominate new installations. ^{5, 6, 10}

For the broader source-security framework these devices sit inside, see our companion guides to radioactive source security under Part 37 and nationally tracked sources and the NSTS.

Key Technical Principles

Delivering a validated dose

Blood irradiation has a well-defined dose target. U.S. FDA guidance and AABB standards call for 25 Gy to the central plane of the blood container, with no point receiving less than 15 Gy, to inactivate donor T-lymphocytes and prevent TA-GVHD. This is not an arbitrary number: dosimetry studies show that about 25 Gy achieves greater than a 5-log reduction in clonogenic T cells, while sparing red cells, platelets, and granulocytes at that level. ^{2, 7, 8}

The dose delivered to the sample is the product of the internal dose rate and the exposure time:

D = \dot{D} (t) \cdot T_{timer}

so the timer needed to reach a target dose is:

T_{timer} = \frac{D _{target}}{D ˙ ( t )}

Why the timer cannot be set once

The internal dose rate falls exponentially as the source decays:

\dot{D} (t) = \dot{D}_{0} e^{- λ t}, λ = \frac{ln 2}{T _{1/2}}

Consider a cobalt-60 research irradiator with an initial dose rate of $\dot{D}_{0} = 8 Gy/min$ . To deliver a 25 Gy dose at installation:

T_{timer} = \frac{25}{8} = 3.1 min

Two years later, with $T_{1/2} = 5.27$ years:

\dot{D} (2) = 8 \cdot e^{- \frac{l n 2}{5.27} \times 2} = 8 \cdot e^{- 0.263} = 6.16 Gy/min

T_{timer} = \frac{25}{6.16} = 4.06 min

If the operator had never updated the timer, the sample would receive only $6.16 \times 3.1 \approx 19 Gy$ — below the 15 Gy floor at some points in the canister and a potential TA-GVHD failure. For cesium-137 the drift is far slower (about 2% per year), but it is still real and still must be corrected. This is why periodic dose-mapping (timer or dose-rate calibration) of the chamber is a core QC task, not an optional one. ⁵

Shielding and accessible dose rates

Although Part 36 does not apply, the device is a registered sealed-source-and-device (SS&D) product with design limits on the radiation level at its accessible external surfaces, and the facility must verify those by survey at acceptance and periodically. The physics is ordinary attenuation — the tenth-value layer (TVL) of the shielding material sets how thick the cabinet must be to bring 662 keV or MeV-range photons down to a safe surface dose rate. The same time–distance–shielding logic that governs every external-dose problem applies here; see time, distance, and shielding for external dose and lead shielding design principles. ³

Clinical Impact

For a blood irradiator, radiation safety and clinical efficacy are the same problem: an out-of-calibration timer that under-doses blood is simultaneously a QC failure and a patient-safety event, because under-irradiated units can cause fatal TA-GVHD in immunocompromised recipients. ^{2, 8}

Transfusion safety. TA-GVHD is nearly always fatal, and irradiation is the standard prevention for at-risk recipients. A validated, decay-corrected dose is what makes the intervention effective. ^{2, 8}
Research integrity. In a research irradiator, an unverified dose invalidates experiments — an under- or over-irradiated cell or animal cohort produces data that cannot be reproduced.
Occupational protection. In normal use, staff dose is negligible because the source stays shielded. The realistic exposure risks are a stuck source or canister, a shielding or interlock defect, or — the serious one — a source-handling event during service, relocation, or disposal. The program must be built for those low-probability, high-consequence moments. ⁵
Institutional risk. A large sealed source is a decades-long liability: security obligations, eventual disposal cost, and regulatory exposure. Recognizing that lifecycle is part of managing the device responsibly. ^{6, 10}

Practical Optimization Tips

Run the source-specific safety basics

Regardless of isotope, a self-contained gamma irradiator program should include:

Semiannual sealed-source leak testing to detect any loss of source integrity — see sealed source leak testing.
Interlock and timer verification, so the sample cannot be loaded with shielding open and the exposure terminates correctly.
Periodic dose-mapping / timer calibration corrected for decay, as shown above.
Radiation surveys of accessible surfaces at acceptance and on a defined schedule.
Source inventory and physical security under Part 37 where the quantity applies.
Operator training and written procedures, plus RSO oversight.

Treat Part 37 as a design constraint, not paperwork

If the source is a Category 1 or 2 quantity, the security plan (access control, monitoring, background checks for individuals with unescorted access, coordinated response) is a real operational requirement, not a binder. Build it into staffing and facility access from the start.

Plan the end of life early

Sealed sources do not disappear when a device is decommissioned. Disposal pathways and costs should be understood before the device is even purchased, and certainly before it is relocated or retired. Coordinate with radioactive material license support for amendments, transfer, and disposal.

Seriously evaluate x-ray replacement

For blood and many research applications, x-ray irradiators deliver an equivalent biological result with no radioactive source — removing leak testing, Part 37 security, and disposal liability. National programs have supported replacement. Weigh capital cost, tube and electrical maintenance, and dose-validation against the multi-decade security and disposal burden of a gamma source. ^{6, 10}

Common pitfalls to avoid

Assuming Part 36 governs the device. It does not; the framework is Part 30/37 and NUREG-1556 Volume 5. ^{1, 5}
Setting the timer once. Source decay makes a fixed timer progressively wrong. ⁵
Underrating security. A large Cs-137 source is a national-security-relevant material, not just a licensing line item. ^{3, 6}
Ignoring disposal until decommissioning. The cost and logistics can be substantial and should be planned early.
Skipping dose-mapping after service or relocation, which can disturb source geometry or shielding.

Regulatory Considerations

Self-contained irradiators are licensed for possession of byproduct material under 10 CFR Part 30 (or an Agreement State equivalent), secured under Part 37 when the quantity applies, and operated within the dose limits of Part 20 — with device-specific guidance in NUREG-1556 Volume 5. Part 36 is not the operative rule. ^{1, 4, 5}

10 CFR Part 30 — Rules of General Applicability to Domestic Licensing of Byproduct Material. The possession license and its conditions (authorized use, RSO, procedures) govern the device. ⁴
10 CFR Part 37 — Physical Protection of Category 1 and Category 2 Quantities of Radioactive Material. Under Appendix A, the cesium-137 Category 1 threshold is 100 TBq (about 2,700 Ci) and Category 2 is 1 TBq (about 27 Ci); for cobalt-60 the thresholds are 30 TBq (about 810 Ci) and 0.3 TBq (about 8.1 Ci). A typical blood-irradiator source in the ~1,000–2,500 Ci range is therefore a Category 1 or 2 quantity, triggering Part 37 security. ³
10 CFR Part 20 — Standards for Protection Against Radiation. Occupational and public dose limits set the acceptance and survey design goals for the device's shielding and access controls. ¹¹
NRC NUREG-1556, Volume 5 — Program-Specific Guidance About Self-Shielded Irradiator Licenses (Revision 1) is the consolidated NRC guidance for these licenses, covering source security, leak testing, and radiation safety procedures. The NRC has also issued a specific policy on protecting cesium-137 chloride sources. ⁵
FDA guidance on gamma irradiation of blood products establishes the 25 Gy / minimum 15 Gy dose expectation for blood irradiation; AABB standards align with it. ⁷

Agreement States administer equivalent programs. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States, while Washington, DC and Delaware are regulated directly by the NRC. A facility must confirm which authority licenses the device, and coordinate the program with RSO consulting, license support, and staff training. For related security obligations, see securing licensed material under 20.1801–1802.

Frequently Asked Questions (FAQs)

What is a self-contained irradiator?

A self-contained (self-shielded) irradiator is a shielded cabinet in which a sealed radioactive source, usually cesium-137 or cobalt-60, or an x-ray tube delivers a controlled radiation dose to a sample placed inside. Common examples are blood irradiators used to prevent transfusion-associated graft-versus-host disease and research irradiators used for cell and animal studies. The source and the irradiation chamber are enclosed so personnel are not exposed during normal operation.

Are self-contained irradiators regulated under 10 CFR Part 36?

No. 10 CFR Part 36 applies to large panoramic and underwater (pool-type) irradiators, and it specifically excludes self-shielded irradiators and irradiators used to treat humans or animals medically. Self-contained gamma irradiators are licensed for possession of byproduct material under 10 CFR Part 30 and related parts, with device-specific conditions and NRC guidance in NUREG-1556 Volume 5.

Why is the cesium-137 source in a blood irradiator a security concern?

A typical self-contained irradiator holds on the order of a thousand to a few thousand curies of cesium-137. That is a Category 1 or Category 2 quantity of radioactive material under 10 CFR Part 37 Appendix A, which triggers physical-security requirements. Cesium-137 chloride is also a dispersible powder, which is why the NRC issued a specific source-protection policy and why national programs are encouraging replacement with x-ray devices.

Why does the irradiation timer need to be recalculated over time?

The dose rate inside the chamber falls as the source decays. Cobalt-60 (half-life about 5.27 years) loses roughly 1 percent of its output per month, and cesium-137 (half-life about 30 years) falls more slowly. The timer that delivers the target dose must be corrected for decay, verified by periodic dose-mapping (timer or dose-rate calibration), so that under-dosing or over-dosing does not occur.

What dose is used to irradiate blood, and why?

U.S. FDA guidance and AABB standards call for delivering 25 Gy to the central plane of the blood container with no point receiving less than 15 Gy. This inactivates donor T-lymphocytes to prevent transfusion-associated graft-versus-host disease; studies show about 25 Gy achieves greater than a 5-log reduction in clonogenic T cells.

What routine radiation safety checks does a self-contained irradiator need?

Typical elements include semiannual sealed-source leak testing, source inventory and physical security under Part 37 where applicable, interlock and timer function checks, periodic dose-mapping or timer calibration, radiation surveys of accessible surfaces, personnel dosimetry as warranted, operator training, and documented procedures — all overseen by the Radiation Safety Officer and consistent with the license and NUREG-1556 Volume 5.

Should a facility replace its cesium irradiator with an x-ray unit?

Many facilities are doing so. X-ray blood and research irradiators deliver an equivalent biological result without a radioactive source, eliminating the Part 37 security burden, leak testing, and eventual disposal. National programs offer support for replacement. The trade-offs are capital cost, tube and electrical maintenance, and validating dose delivery, so the decision should weigh security, lifecycle cost, and operational needs.

Key Takeaways

They are not Part 36 devices. Self-shielded irradiators are licensed under Part 30, secured under Part 37, and guided by NUREG-1556 Volume 5 — Part 36 governs panoramic and pool irradiators, not these.
The source is a security asset. A ~1,000–2,500 Ci Cs-137 source is a Category 1 or 2 quantity under Part 37 Appendix A, and cesium chloride is dispersible.
The timer drifts with decay. $\dot{D} (t) = \dot{D}_{0} e^{- λ t}$ means a fixed timer under-doses over time; Co-60 drifts ~1%/month, Cs-137 ~2%/year.
Blood dose is defined: 25 Gy central plane, minimum 15 Gy anywhere, for a greater than 5-log T-cell reduction to prevent TA-GVHD.
Run the fundamentals: leak testing, interlock and timer checks, dose-mapping, surveys, inventory, security, training, and RSO oversight.
Consider x-ray replacement, which removes the source, the security burden, and the disposal liability.

Conclusion

A self-contained irradiator is deceptively simple to operate and genuinely demanding to steward. The device is safe in daily use precisely because engineering keeps the source shielded — but that same design can lull a program into treating a Category-quantity radioactive source like a countertop appliance. The three anchoring facts keep the program honest: the regulatory framework is Part 30/37 and NUREG-1556 Volume 5 rather than Part 36, the source is a security-significant quantity, and the delivered dose declines with decay and must be re-verified.

For blood irradiators especially, radiation safety and patient safety are one and the same — a validated dose prevents a fatal transfusion complication. Facilities weighing the multi-decade security and disposal burden of a gamma source against the operating cost of an x-ray unit increasingly find that replacement is the more defensible long-term choice.

How DRPS Can Help

Diagnostic Radiation Physics Services helps hospitals, blood banks, and research institutions run defensible irradiator programs. This may include acceptance and periodic radiation surveys, dose-mapping and timer-calibration review, leak-test and inventory program setup, Part 37 security-plan support, license amendments and disposal or replacement planning, operator training, and RSO oversight — integrated with Radiation Safety Officer consulting, radioactive material license support, and radiation safety training.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong irradiator program treats the source as what it is — a powerful, long-lived, security-significant asset that deserves deliberate management from purchase through disposal.

Related Resources

References

U.S. Nuclear Regulatory Commission. 10 CFR Part 36: Licenses and Radiation Safety Requirements for Irradiators (scope, § 36.1 — self-shielded irradiators excluded). ecfr.gov
Góes EG, Borges JC, Covas DT, et al. Quality control of blood irradiation: determination of T cells radiosensitivity to cobalt-60 gamma rays. Transfusion. 2006;46(1):34-40. doi:10.1111/j.1537-2995.2005.00669.x. PubMed
U.S. Nuclear Regulatory Commission. 10 CFR Part 37: Physical Protection of Category 1 and Category 2 Quantities of Radioactive Material (Appendix A thresholds). ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 30: Rules of General Applicability to Domestic Licensing of Byproduct Material. ecfr.gov
U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 5, Revision 1: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Self-Shielded Irradiator Licenses. 2018. nrc.gov
National Academies of Sciences, Engineering, and Medicine. Radioactive Sources: Applications and Alternative Technologies. Washington, DC: The National Academies Press; 2021. nap.edu
U.S. Food and Drug Administration. Recommendations Regarding License Amendments and Procedures for Gamma Irradiation of Blood Products (25 Gy / minimum 15 Gy). fda.gov
AABB. Standards for Blood Banks and Transfusion Services (irradiation dose: 25 Gy central, minimum 15 Gy). aabb.org
U.S. Nuclear Regulatory Commission. Policy Statement on the Protection of Cesium-137 Chloride Sources. 2011. nrc.gov
U.S. Department of Energy, National Nuclear Security Administration, Office of Radiological Security. Cesium Irradiator Replacement Project (CIRP). energy.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov